Nipro Corp – Strategy, SWOT and Corporate Finance Report
- Pages: 44
- Published: October 2019
- Report Code: MLME4704FSA
Nipro Corp – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company
Key Highlights
Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, half-type kits among others. It offers contract manufacturing services of injection, oral and external use drug formulations. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has sales offices in North America, South America, Europe, Asia and Africa. Nipro is headquartered in Osaka, Japan.
Scope
Detailed information on Nipro Corp required for business and competitor intelligence needs
A study of the major internal and external factors affecting Nipro Corp in the form of a SWOT analysis
An in-depth view of the business model of Nipro Corp including a breakdown and examination of key business segments
News about Nipro Corp, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Nipro Corp and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Nipro Corp as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Nipro Corps business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Terumo Corp
Taiho Pharmaceutical Co Ltd
Mitsubishi Tanabe Pharma Corp
Maquet Holding BV & Co KG
Kyowa Kirin Co Ltd
Fresenius SE & Co KGaA
Chugai Pharmaceutical Co Ltd
B. Braun Melsungen AG
Asahi Kasei Medical Co Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple report purchases.